Neurocognition with maraviroc compared with tenofovir in HIV

A prospective cohort study of neurocognitive function in aviremic HIV-infected patients treated with 1 or 3 antiretrovirals

Pérez-Valero, Ignacio
González-Baeza, Alicia
Estébanez, Miriam
Monge, Susana
Montes-Ramírez, M. L.
Bayón, Carmen
Pulido, Federico
Bernardino, José Ignacio
Zamora, F. X.
González García, J. J.
Lagarde, María
Hernando Jeréz, María Asunción
Arnalich, Francisco
Arribas, José R.

January 2014

The evolution of neurocognitive performance in aviremic human immunodeficiency virus (HIV)– positi...

Changes in cognitive function over 96 weeks in naive patients randomized to darunavir-ritonavir plus either raltegravir or tenofovir-emtricitabine: A substudy of the NEAT001/ANRS143 trial

Winston, Alan
Gatell, Jose
Grarup, Jesper
Pozniak, Anton Louis
Babiker, Abdel
Raffi, François
Richert, Laura
Stöhr, Wolfgang
Antinori, Andrea
Amieva, Hélène
Perre, Philippe
De Wit, Stéphane
Reynes, Jacques
Gompels, Mark
d'Arminio Monforte, Antonella

February 2017

Background: Improvements in cognitive function are described after initiation of combination antiret...

Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch

Tiraboschi, Juan M.
Muñoz-Moreno, José A.
Puertas, M.C.
Alonso-Villaverde, C.
Prats, A.
Ferrer, Elena
Rozas N.
Masó, Margarita
Ouchi, Dan
Martinez Picado, Francisco Javier
Podzamczer Palter, Daniel

January 2015

Objectives: The aim of the study was to evaluate HIV-1 viral load (VL) and inflammatory markers in c...

Neurocognition with maraviroc compared with tenofovir in HIV

Robertson, Kevin R.
Miyahara, Sachiko
Lee, Anthony
Brown, Todd T.
Chan, Ellen S.
Berzins, Baiba
Rusin, David
Eron, Joseph J.
Taiwo, Babafemi O.

January 2016

To determine whether maraviroc (MVC) has unique neurocognitive benefits in the context of initial an...

Changes in cerebral function parameters with maraviroc-intensified antiretroviral therapy in treatment naive HIV-positive individuals

Mora-Peris, Borja
Bouliotis, Georgios
Ranjababu, Kulasegaram
Clarke, Amanda
Post, Frank A.
Nelson, Mark
Burgess, Laura
Tiraboschi, Juan
Khoo, Saye
Taylor, Steve
Ashby, Deborah
Winston, Alan

May 2018

Background: Maraviroc-intensified antiretroviral therapy (ART) may be associated with cognitive bene...

Changes in Cerebral Function Parameters with Maraviroc Intensified Antiretroviral Therapy in Treatment Naïve HIV-Positive Individuals; A Randomised Controlled Study.

Mora-Peris, Borja
Bouliotis, George
Ranjababu, Kulasegaram
Clarke, Amanda
Post, Frank A
Nelson, Mark
Burgess, Laura
Tiraboschi, Juan
Khoo, Saye
Taylor, Steven
Ashby, Deborah
Winston, Alan

February 2018

BACKGROUND Maraviroc-intensified antiretroviral therapy (ART) may be associated with cognitive be...

Penetration and antiviral activity of antiretroviral drugs in the Central Nervous System

Tiraboschi, Juan Manuel

October 2016

[eng] INTRODUCTION: With successful treatment and near-normal life expectancy of people living with ...

Robertson, K.
Maruff, P.
Ross, L.L.
Wohl, D.
Small, C.B.
Edelstein, H.
Shaefer, M.S.

January 2019

Human immunodeficiency virus (HIV)-associated neurocognitive disorders can persist in many patients ...

Effect of Antiretroviral Therapy on Blood-Brain Barrier Integrity and Central Nervous System Inflammation

Kettlewell, Joanna Marie

January 2020

Human immunodeficiency virus type 1 (HIV) enters the central nervous system (CNS) as early as eight ...

Robertson, K
Maruff, P
Ross, LL
Wohl, D
Small, CB
Edelstein, H
Shaefer, MS

February 2019

Human immunodeficiency virus (HIV)-associated neurocognitive disorders can persist in many patients ...

Improved Neuropsychological and Neurological Functioning Across Three Antiretroviral Regimens in Diverse Resource-Limited Settings: AIDS Clinical Trials Group Study A5199, the International Neurological Study

Robertson, K
Jiang, H
Kumwenda, J
Supparatpinyo, K
Evans, S
Campbell, TB
Price, R
Tripathy, S
Kumarasamy, N
La Rosa, A
Santos, B
Silva, MT
Montano, S
Kanyama, C
Faesen, S
Murphy, R
Hall, C
Marra, CM
Marcus, C
Berzins, B
Allen, R
Housseinipour, M
Amod, F
Sanne, I
Hakim, J
Walawander, A
Nair, A

September 2012

BackgroundAIDS Clinical Trials Group (ACTG) A5199 compared the neurological and neuropsychological (...

Antiretroviral neurotoxicity

Robertson, Kevin
Liner, Jeff
Meeker, Rick B.

January 2012

Combination antiretroviral therapy (CART) has proven to effectively suppress systemic HIV burden, ho...

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

Marra, Christina M.
Zhao, Yu
Clifford, David B.
Letendre, Scott
Evans, Scott
Henry, Katherine
Ellis, Ronald J.
Rodriguez, Benigno
Coombs, Robert W.
Schifitto, Giovanni
McArthur, Justin C.
Robertson, Kevin

January 2009

Determine if antiretroviral (ARV) regimens with good central nervous system (CNS) penetration contro...

Robertson, Kevin
Maruff, Paul
Ross, Lisa L.
Wohl, David
Small, Catherine B.
Edelstein, Howard
Shaefer, Mark S.

February 2019

Human immunodeficiency virus (HIV)-associated neurocognitive disorders can persist in many patients ...

Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort

Smurzynski, Marlene
Wu, Kunling
Letendre, Scott
Robertson, Kevin
Bosch, Ronald J.
Clifford, David B.
Evans, Scott
Collier, Ann C.
Taylor, Michael
Ellis, Ronald

January 2011

Differences in antiretroviral (ARV) distribution into the central nervous system (CNS) may impact ne...

A prospective cohort study of neurocognitive function in aviremic HIV-infected patients treated with 1 or 3 antiretrovirals

Pérez-Valero, Ignacio
González-Baeza, Alicia
Estébanez, Miriam
Monge, Susana
Montes-Ramírez, M. L.
Bayón, Carmen
Pulido, Federico
Bernardino, José Ignacio
Zamora, F. X.
González García, J. J.
Lagarde, María
Hernando Jeréz, María Asunción
Arnalich, Francisco
Arribas, José R.

January 2014

The evolution of neurocognitive performance in aviremic human immunodeficiency virus (HIV)– positi...

Changes in cognitive function over 96 weeks in naive patients randomized to darunavir-ritonavir plus either raltegravir or tenofovir-emtricitabine: A substudy of the NEAT001/ANRS143 trial

Winston, Alan
Gatell, Jose
Grarup, Jesper
Pozniak, Anton Louis
Babiker, Abdel
Raffi, François
Richert, Laura
Stöhr, Wolfgang
Antinori, Andrea
Amieva, Hélène
Perre, Philippe
De Wit, Stéphane
Reynes, Jacques
Gompels, Mark
d'Arminio Monforte, Antonella

February 2017

Background: Improvements in cognitive function are described after initiation of combination antiret...

Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch

Tiraboschi, Juan M.
Muñoz-Moreno, José A.
Puertas, M.C.
Alonso-Villaverde, C.
Prats, A.
Ferrer, Elena
Rozas N.
Masó, Margarita
Ouchi, Dan
Martinez Picado, Francisco Javier
Podzamczer Palter, Daniel

January 2015

Objectives: The aim of the study was to evaluate HIV-1 viral load (VL) and inflammatory markers in c...

Neurocognition with maraviroc compared with tenofovir in HIV

Robertson, Kevin R.
Miyahara, Sachiko
Lee, Anthony
Brown, Todd T.
Chan, Ellen S.
Berzins, Baiba
Rusin, David
Eron, Joseph J.
Taiwo, Babafemi O.

January 2016

To determine whether maraviroc (MVC) has unique neurocognitive benefits in the context of initial an...

Changes in cerebral function parameters with maraviroc-intensified antiretroviral therapy in treatment naive HIV-positive individuals

Mora-Peris, Borja
Bouliotis, Georgios
Ranjababu, Kulasegaram
Clarke, Amanda
Post, Frank A.
Nelson, Mark
Burgess, Laura
Tiraboschi, Juan
Khoo, Saye
Taylor, Steve
Ashby, Deborah
Winston, Alan

May 2018

Background: Maraviroc-intensified antiretroviral therapy (ART) may be associated with cognitive bene...

Changes in Cerebral Function Parameters with Maraviroc Intensified Antiretroviral Therapy in Treatment Naïve HIV-Positive Individuals; A Randomised Controlled Study.

Mora-Peris, Borja
Bouliotis, George
Ranjababu, Kulasegaram
Clarke, Amanda
Post, Frank A
Nelson, Mark
Burgess, Laura
Tiraboschi, Juan
Khoo, Saye
Taylor, Steven
Ashby, Deborah
Winston, Alan

February 2018

BACKGROUND Maraviroc-intensified antiretroviral therapy (ART) may be associated with cognitive be...

Penetration and antiviral activity of antiretroviral drugs in the Central Nervous System

Tiraboschi, Juan Manuel

October 2016

[eng] INTRODUCTION: With successful treatment and near-normal life expectancy of people living with ...

Robertson, K.
Maruff, P.
Ross, L.L.
Wohl, D.
Small, C.B.
Edelstein, H.
Shaefer, M.S.

January 2019

Human immunodeficiency virus (HIV)-associated neurocognitive disorders can persist in many patients ...

Effect of Antiretroviral Therapy on Blood-Brain Barrier Integrity and Central Nervous System Inflammation

Kettlewell, Joanna Marie

January 2020

Human immunodeficiency virus type 1 (HIV) enters the central nervous system (CNS) as early as eight ...

Robertson, K
Maruff, P
Ross, LL
Wohl, D
Small, CB
Edelstein, H
Shaefer, MS

February 2019

Human immunodeficiency virus (HIV)-associated neurocognitive disorders can persist in many patients ...

Improved Neuropsychological and Neurological Functioning Across Three Antiretroviral Regimens in Diverse Resource-Limited Settings: AIDS Clinical Trials Group Study A5199, the International Neurological Study

Robertson, K
Jiang, H
Kumwenda, J
Supparatpinyo, K
Evans, S
Campbell, TB
Price, R
Tripathy, S
Kumarasamy, N
La Rosa, A
Santos, B
Silva, MT
Montano, S
Kanyama, C
Faesen, S
Murphy, R
Hall, C
Marra, CM
Marcus, C
Berzins, B
Allen, R
Housseinipour, M
Amod, F
Sanne, I
Hakim, J
Walawander, A
Nair, A

September 2012

BackgroundAIDS Clinical Trials Group (ACTG) A5199 compared the neurological and neuropsychological (...

Antiretroviral neurotoxicity

Robertson, Kevin
Liner, Jeff
Meeker, Rick B.

January 2012

Combination antiretroviral therapy (CART) has proven to effectively suppress systemic HIV burden, ho...

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

Marra, Christina M.
Zhao, Yu
Clifford, David B.
Letendre, Scott
Evans, Scott
Henry, Katherine
Ellis, Ronald J.
Rodriguez, Benigno
Coombs, Robert W.
Schifitto, Giovanni
McArthur, Justin C.
Robertson, Kevin

January 2009

Determine if antiretroviral (ARV) regimens with good central nervous system (CNS) penetration contro...

Robertson, Kevin
Maruff, Paul
Ross, Lisa L.
Wohl, David
Small, Catherine B.
Edelstein, Howard
Shaefer, Mark S.

February 2019

Human immunodeficiency virus (HIV)-associated neurocognitive disorders can persist in many patients ...

Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort

Smurzynski, Marlene
Wu, Kunling
Letendre, Scott
Robertson, Kevin
Bosch, Ronald J.
Clifford, David B.
Evans, Scott
Collier, Ann C.
Taylor, Michael
Ellis, Ronald

January 2011

Differences in antiretroviral (ARV) distribution into the central nervous system (CNS) may impact ne...

A prospective cohort study of neurocognitive function in aviremic HIV-infected patients treated with 1 or 3 antiretrovirals

Pérez-Valero, Ignacio
González-Baeza, Alicia
Estébanez, Miriam
Monge, Susana
Montes-Ramírez, M. L.
Bayón, Carmen
Pulido, Federico
Bernardino, José Ignacio
Zamora, F. X.
González García, J. J.
Lagarde, María
Hernando Jeréz, María Asunción
Arnalich, Francisco
Arribas, José R.

January 2014

The evolution of neurocognitive performance in aviremic human immunodeficiency virus (HIV)– positi...

Changes in cognitive function over 96 weeks in naive patients randomized to darunavir-ritonavir plus either raltegravir or tenofovir-emtricitabine: A substudy of the NEAT001/ANRS143 trial

Winston, Alan
Gatell, Jose
Grarup, Jesper
Pozniak, Anton Louis
Babiker, Abdel
Raffi, François
Richert, Laura
Stöhr, Wolfgang
Antinori, Andrea
Amieva, Hélène
Perre, Philippe
De Wit, Stéphane
Reynes, Jacques
Gompels, Mark
d'Arminio Monforte, Antonella

February 2017

Background: Improvements in cognitive function are described after initiation of combination antiret...

Viral and inflammatory markers in cerebrospinal fluid of patients with HIV-1-associated neurocognitive impairment during antiretroviral treatment switch

Tiraboschi, Juan M.
Muñoz-Moreno, José A.
Puertas, M.C.
Alonso-Villaverde, C.
Prats, A.
Ferrer, Elena
Rozas N.
Masó, Margarita
Ouchi, Dan
Martinez Picado, Francisco Javier
Podzamczer Palter, Daniel

January 2015

Objectives: The aim of the study was to evaluate HIV-1 viral load (VL) and inflammatory markers in c...

Neurocognition with maraviroc compared with tenofovir in HIV

Abstract

Extracted data

Neurocognition with maraviroc compared with tenofovir in HIV

Abstract

Extracted data

Related items

Related items